| KN5501 / Nanjing Enricnk Biotech |
NCT05673447: The Study of Anti-CD19 CAR NK Cells in the Treatment of Relapsed/Refractory Diffuse Large B Cell Lymphoma |
|
|
| Recruiting | 1 | 12 | RoW | anti-CD19 CAR NK cells | Changhai Hospital, Nanjing Enricnk Biotech Co., Ltd | Diffuse Large B Cell Lymphoma | 12/23 | 12/24 | | |
NCT06318533: A Clinical Study of CD19 CAR NK Cells for the Treatment of Relapsed/Refractory B-cell Related Autoimmune Diseases |
|
|
| Recruiting | 1 | 15 | RoW | anti-CD19 CAR NK cells | YANRU WANG, Rui Therapeutics Co., Ltd | Autoimmune Diseases | 03/25 | 03/26 | | |
NCT06337474: An Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Primary Immune Thrombocytopenia |
|
|
| Not yet recruiting | 1 | 9 | NA | anti-CD19 CAR NK cells (KN5501) | Changzhou No.2 People's Hospital, Rui Therapeutics Co., Ltd | Thrombocytopenia Alloimmune | 03/25 | 03/26 | | |
NCT06469190: An Exploratory Clinical Study of Anti-CD19 CAR NK Cell (KN5501) in the Treatment of Relapsed/Refractory Immune Nephropathy |
|
|
| Not yet recruiting | 1 | 36 | NA | KN5501 | Changhai Hospital, Rui Therapeutics | Nephropathy | 06/25 | 06/26 | | |
NCT06010472: An Exploratory Clinical Study of Anti-CD19 CAR NK Cells in the Treatment of Systemic Lupus Erythematosus |
|
|
| Recruiting | 1 | 12 | RoW | anti-CD19 CAR NK cells (KN5501) | Changhai Hospital, Rui Therapeutics Co., Ltd | Systemic Lupus Erythematosus (SLE) | 08/24 | 08/25 | | |
